ArticleAnnals of the rheumatic diseases2022

The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study.

Gregory McDermott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.